Randal Chatman
Directeur Général chez ThermoTek, Inc.
Profil
Before joining ThermoTek Corporation as Chief Executive Officer, Randal C.
(Randy) Chatman served as Vice President of Strategic Contracting, Pricing, National Accounts, Reimbursement & Market Access at Wright Medical Group (NASDAQ: WMGI, acquired by Stryker Corporation, NYSE: SYK).
Mr. Chatman has over twenty-five years of medical device experience as an accomplished senior executive with Stryker Corporation, Medtronic and Johnson & Johnson.
He served in key leadership roles in Sales, Corporate Accounts, Marketing, Pricing, Business Development, Reimbursement and Market Access.
Randy is a graduate of the University of Oklahoma with a B.A.
in Business Communications, and he earned an Associate Fellowship from the University of Pennsylvania Wharton School of Business in The Leonard Davis Institute of Health Economics.
Postes actifs de Randal Chatman
| Sociétés | Poste | Début |
|---|---|---|
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Private Equity Investor | - |
ThermoTek, Inc.
 ThermoTek, Inc. Medical SpecialtiesHealth Technology ThermoTek, Inc. provides medical, aesthetic and thermal management device. It provides a broad range of temperature management solutions to the medical and industrial end markets, specifically cold compression devices used in post-orthopedic surgery rehabilitation and cooling units used in industrial applications. The company was founded by Tony Quisenberry in 1993 and is headquartered in Flower Mound, TX. | Directeur Général | 01/03/2021 |
Anciens postes connus de Randal Chatman
| Sociétés | Poste | Fin |
|---|---|---|
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Directeur/Membre du Conseil | - |
Biomerix Corp.
 Biomerix Corp. Chemicals: SpecialtyProcess Industries Biomerix Corp. engages in the development and manufacture of porous polyurethane materials. The company was founded by Steven I. Hochberg, Peter David Constantino, and Andrew Massik in 2001 and is headquartered in New York, NY. | Sales & Marketing | - |
Formation de Randal Chatman
| University of Oklahoma | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Biomerix Corp.
Biomerix Corp. Chemicals: SpecialtyProcess Industries Biomerix Corp. engages in the development and manufacture of porous polyurethane materials. The company was founded by Steven I. Hochberg, Peter David Constantino, and Andrew Massik in 2001 and is headquartered in New York, NY. | Process Industries |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
ThermoTek, Inc.
ThermoTek, Inc. Medical SpecialtiesHealth Technology ThermoTek, Inc. provides medical, aesthetic and thermal management device. It provides a broad range of temperature management solutions to the medical and industrial end markets, specifically cold compression devices used in post-orthopedic surgery rehabilitation and cooling units used in industrial applications. The company was founded by Tony Quisenberry in 1993 and is headquartered in Flower Mound, TX. | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |